glp 1 weight loss medication List of approved and pending GLP-1 medications GLP-1 Weight Loss Medications Explained:
Description
In the STEP-1 trial, 1,961 patients were followed for 68 weeks and underwent randomization to semaglutide or placebo plus lifestyle intervention resulting in14.9% weight loss in the semaglutide group versus 2.5% in the placebo group [33]
Glucagon levels were not measured
Additionally, opting for easily digestible foods, such as cooked vegetables, lean proteins, and low-fat dairy products, may be better tolerated during the initial phases of treatment
The mechanism is dose-dependent but not inevitable
D.SchulteP
The average age of participants was 63 - over a decade past typical menopause onset, which usually occurs around age 51
